Trial Profile
A Prospective, Single-Center Double-Blind Randomized Study in Subjects Undergoing Coronary Computed Tomography Angiography (CCTA) Examination (VISIPAQUE Randomized Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Iodixanol (Primary)
- Indications Cardiovascular disorders
- Focus Diagnostic use
- Acronyms Visipaque
- 10 Apr 2015 New trial record